Compile Data Set for Download or QSAR
Report error Found 170 Enz. Inhib. hit(s) with all data for entry = 6325
TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123235(US8742110, 3-20)
Affinity DataIC50: 0.129nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123247(US8742110, 4-11)
Affinity DataIC50: 0.152nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123253(US8742110, 4-17)
Affinity DataIC50: 0.165nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123270(US8742110, 5-6)
Affinity DataIC50: 0.172nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123248(US8742110, 4-12)
Affinity DataIC50: 0.188nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123300(US8742110, 6-18)
Affinity DataIC50: 0.225nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123254(US8742110, 4-18)
Affinity DataIC50: 0.228nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123271(US8742110, 5-7)
Affinity DataIC50: 0.233nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123255(US8742110, 4-19)
Affinity DataIC50: 0.243nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123296(US8742110, 6-14)
Affinity DataIC50: 0.260nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123252(US8742110, 4-16)
Affinity DataIC50: 0.272nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123277(US8742110, 5-13)
Affinity DataIC50: 0.317nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123227(US8742110, 3-12)
Affinity DataIC50: 0.323nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123306(US8742110, 6-24)
Affinity DataIC50: 0.342nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123234(US8742110, 3-19)
Affinity DataIC50: 0.359nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123264(US8742110, 4-28)
Affinity DataIC50: 0.395nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123257(US8742110, 4-21)
Affinity DataIC50: 0.397nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123250(US8742110, 4-14)
Affinity DataIC50: 0.407nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123243(US8742110, 4-7)
Affinity DataIC50: 0.409nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123179(US8742110, 1-28)
Affinity DataIC50: 0.421nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123272(US8742110, 5-8)
Affinity DataIC50: 0.424nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123236(US8742110, 3-21)
Affinity DataIC50: 0.437nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123245(US8742110, 4-9)
Affinity DataIC50: 0.439nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123258(US8742110, 4-22)
Affinity DataIC50: 0.468nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123244(US8742110, 4-8)
Affinity DataIC50: 0.474nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123239(US8742110, 4-3)
Affinity DataIC50: 0.490nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123240(US8742110, 4-4)
Affinity DataIC50: 0.502nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123242(US8742110, 4-6)
Affinity DataIC50: 0.546nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123307(US8742110, 6-25)
Affinity DataIC50: 0.550nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123241(US8742110, 4-5)
Affinity DataIC50: 0.556nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123180(US8742110, 1-29)
Affinity DataIC50: 0.582nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123256(US8742110, 4-20)
Affinity DataIC50: 0.632nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123269(US8742110, 5-5)
Affinity DataIC50: 0.650nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123266(US8742110, 5-2)
Affinity DataIC50: 0.704nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123311(US8742110, 6-29)
Affinity DataIC50: 0.705nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123176(US8742110, 1-25)
Affinity DataIC50: 0.740nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123216(US8742110, 3-1)
Affinity DataIC50: 0.768nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123237(US8742110, 4-1)
Affinity DataIC50: 0.793nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123298(US8742110, 6-16)
Affinity DataIC50: 0.851nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123226(US8742110, 3-11)
Affinity DataIC50: 0.941nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123153(US8742110, 1-2)
Affinity DataIC50: 0.943nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123267(US8742110, 5-3)
Affinity DataIC50: 0.980nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123249(US8742110, 4-13)
Affinity DataIC50: 0.983nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123302(US8742110, 6-20)
Affinity DataIC50: 1.06nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123260(US8742110, 4-24)
Affinity DataIC50: 1.13nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123233(US8742110, 3-18)
Affinity DataIC50: 1.15nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123231(US8742110, 3-16)
Affinity DataIC50: 1.18nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123224(US8742110, 3-9)
Affinity DataIC50: 1.21nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123279(US8742110, 5-15)
Affinity DataIC50: 1.25nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

TargetSomatostatin receptor type 5(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM123184(US8742110, 1-33)
Affinity DataIC50: 1.29nMpH: 7.8Assay Description:SSTR5 binding assays can be performed by labeling somatostatin and determining the ability of a compound to inhibit somatostatin binding. (Poitout et...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/4/2014
Entry Details
Go to US Patent

Displayed 1 to 50 (of 170 total ) | Next | Last >>
Jump to: